VLP-based vaccines that induce immune clearance of senescent cells to treat aging-related diseases, including atherosclerosis. Room-temperature–stable immunotherapy engineered for cold-chain-free global distribution, targeting people seeking extended healthy lifespan and those at risk of heart disease.